Billing for Rebyota fecal microbiota, live-jslm, HCPCS code J1440 -- Avoid rejections
Fecal microbiota, sold under the brand name Rebyota, is used for the prevention of recurrence of Clostridioides difficile (C. diff).
Effective for claims with dates of service on or after July 1, 2023
Providers shall bill Rebyota fecal microbiota, live-jslm (HCPCS code J1440), with fecal microbiota transplantation (FMT) procedure (HCPCS code 0780T) on the same claim. The previous CMS instructions to bill Rebyota (HCPCS code J3490 or J3590) with HCPCS code G0455 (Preparation with instillation of fecal microbiota) expired effective June 30, 2023.
Failure to bill J1440 and 0780T on the same claim for date of service on and after July 1, 2023, will result in a claim rejection.
References